I bought this one several days ago and there is still a huge amount of upside. If it can get through the $4.30 and $4.80 resistance a double is a real deal. They have had solid revenues the last 2 Q and are based in Isreal. They have partnered in a project with Amgen and have been around I think since 2003. The Timeframes tell the story and the flow of the chart and long build up shows possible huge rewards near term. I am long for this company, but relatively short for this run...I think by next week we will be above $5 or $5.50.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.